Iterum Therapeutics

Iterum Therapeutics EBITDA

Delisted·Jul 30, 2026

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Iterum Therapeutics (ITRM) as of Nov 5, 2026 is -18.70 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -47.47 M USD — a change of -60.61% (higher).

EBITDA

-18.70 MUSD

YoY

-60.61%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Iterum Therapeutics is 2024 -18.70 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Iterum Therapeutics was 2023 -47.47 M USD. It decreases by -60.61% higher compared to the previous year.

The Iterum Therapeutics EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
-29.46 M USD
Jan 1, 2018
-76.56 M USD
Jan 1, 2019
-102.02 M USD
Jan 1, 2020
-32.13 M USD
Jan 1, 2021
-24.54 M USD
Jan 1, 2022
-30.38 M USD
Jan 1, 2023
-47.47 M USD
Jan 1, 2024
-18.70 M USD
The Iterum Therapeutics EBITDA history
YEAREBITDAYoY
-18.70 MUSD-60.61%
-47.47 MUSD+56.23%
-30.38 MUSD+23.83%
-24.54 MUSD-23.62%
-32.13 MUSD-68.51%
-102.02 MUSD+33.26%
-76.56 MUSD+159.92%
-29.46 MUSD+120.49%
-13.36 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Iterum Therapeutics Stock analysis

What does Iterum Therapeutics do? Iterum Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Iterum Therapeutics stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Iterum Therapeutics is -18.70 M USD in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Iterum Therapeutics changed from -47.47 M USD to -18.70 M USD, representing a -60.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Iterum Therapeutics since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Iterum Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Iterum Therapeutics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Iterum Therapeutics